These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30369050)

  • 1. Blood-based biopsies-clinical utility beyond circulating tumor cells.
    Tang CM; Zhu P; Li S; Makarova OV; Amstutz PT; Adams DL
    Cytometry A; 2018 Dec; 93(12):1246-1250. PubMed ID: 30369050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filtration and Analysis of Circulating Cancer Associated Cells from the Blood of Cancer Patients.
    Tang CM; Zhu P; Li S; Makarova OV; Amstutz PT; Adams DL
    Methods Mol Biol; 2017; 1572():511-524. PubMed ID: 28299708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
    Adams DL; Adams DK; Alpaugh RK; Cristofanilli M; Martin SS; Chumsri S; Tang CM; Marks JR
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1037-42. PubMed ID: 27197300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy.
    Zhang WW; Rong Y; Liu Q; Luo CL; Zhang Y; Wang FB
    Clin Transl Oncol; 2019 Jul; 21(7):828-835. PubMed ID: 30569214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VTX-1 Liquid Biopsy System for Fully-Automated and Label-Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform.
    Sollier-Christen E; Renier C; Kaplan T; Kfir E; Crouse SC
    Cytometry A; 2018 Dec; 93(12):1240-1245. PubMed ID: 30211979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
    Mu Z; Wang C; Ye Z; Rossi G; Sun C; Li L; Zhu Z; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2017 Oct; 165(3):733-741. PubMed ID: 28687903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated rare single cell picking with the ALS cellcelector™.
    Nelep C; Eberhardt J
    Cytometry A; 2018 Dec; 93(12):1267-1270. PubMed ID: 30184320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology and clinical potential of circulating tumor cells.
    Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
    Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Isolation and Analysis of Circulating Tumor Cells.
    Guo T; Stankiewicz E; Mao X; Lu YJ
    Methods Mol Biol; 2019; 2054():115-128. PubMed ID: 31482451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
    Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
    Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.
    Adams DL; Adams DK; He J; Kalhor N; Zhang M; Xu T; Gao H; Reuben JM; Qiao Y; Komaki R; Liao Z; Edelman MJ; Tang CM; Lin SH
    Clin Cancer Res; 2017 Oct; 23(19):5948-5958. PubMed ID: 28679765
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RareCyte® platform for next-generation analysis of circulating tumor cells.
    Kaldjian EP; Ramirez AB; Sun Y; Campton DE; Werbin JL; Varshavskaya P; Quarre S; George T; Madan A; Blau CA; Seubert R
    Cytometry A; 2018 Dec; 93(12):1220-1225. PubMed ID: 30277660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer circulating tumor cells with mesenchymal features-an unreachable target?
    Topa J; Grešner P; Żaczek AJ; Markiewicz A
    Cell Mol Life Sci; 2022 Jan; 79(2):81. PubMed ID: 35048186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
    Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
    BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
    Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
    Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
    Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
    Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.